Immunovant, Inc. (IMVT)
26.27
+0.27
(+1.04%)
USD |
NASDAQ |
Jan 16, 16:00
26.27
0.00 (0.00%)
After-Hours: 20:00
Immunovant Market Cap: 4.605B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revvity, Inc. | 12.75B |
| Viridian Therapeutics, Inc. | 3.174B |
| Perspective Therapeutics, Inc. | 173.21M |
| Electromed, Inc. | 232.12M |
| InfuSystem Holdings, Inc. | 178.55M |
Market Cap Related Metrics
| PEG Ratio | -0.3353 |
| Price to Book Value | 8.860 |
| Price | 26.27 |
| Earnings Yield | -10.77% |
| PEGY Ratio | -0.3353 |